Inventor · disambiguated record
Markku Jalkanen
Also filed as: JALKANEN MARKKU · JALKANEN MARKKU T
18 granted patents·7 pending applications·82 citations·filing 1993–2021
92Inventor score
Files withFARON PHARMACEUTICALS OY9BIOTIE THERAPIES CORP4JALKANEN SIRPA4BIOTIE THERAPIES LTD2FARON PHARMACEUTICALS OY A FIN1
Top patents by PatentIndex Score
25 records- 0179US11421279B2Method for determining patient's responsiveness to type 1 interferon treatment and use of type 1 interferon to treat patient having specified single nucleoide polymophismFARON PHARMACEUTICALS OY·Filed 2019·Granted Aug 23, 2022·2 cites·13 claims
- 0279US6624202B2Inhibitors of copper-containing amine oxidasesBIOTIE THERAPIES CORP·Filed 2001·Granted Sep 23, 2003·14 cites·15 claims
- 0378US8975081B2Biomarker for monitoring development of diseases and assessing the efficacy of therapiesFARON PHARMACEUTICALS OY·Filed 2013·Granted Mar 10, 2015·2 cites·4 claims
- 0471US6887698B2Glucuronyl C5-epimerase, DNA encoding the same and uses thereofINALCO SPA·Filed 2001·Granted May 3, 2005·3 cites·15 claims
- 0566US10247730B2Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patientFARON PHARMACEUTICALS OY·Filed 2014·Granted Apr 2, 2019·1 cites·15 claims
- 0665US10293030B2Lyophilised pharmaceutical formulation and its useFARON PHARMACEUTICALS OY·Filed 2016·Granted May 21, 2019·1 cites·23 claims
- 0765US7399626B2Glucuronyl C5-epimerase, DNA encoding the same and uses thereofBIOTIE THERAPIES CORP·Filed 2005·Granted Jul 15, 2008·1 cites·24 claims
- 0863US5726058ASyndecan stimulation of cellular differentiationFiled 1995·Granted Mar 10, 1998·20 cites·10 claims
- 0959US2007191408A1Compositions useful especially for treatment or prevention of metabolic syndromeFARON PHARMACEUTICALS OY·Filed 2006·Application pending·0 cites
- 1058US12371486B2Humanized anti clever-1 antibodies and their useFARON PHARMACEUTICALS OY·Filed 2021·Granted Jul 29, 2025·0 cites·27 claims
- 1155US8119651B2Compositions useful especially for treatment or prevention of metabolic syndromeJALKANEN SIRPA·Filed 2008·Granted Feb 21, 2012·0 cites·5 claims
- 1253US10526607B2Cell and therapeutical and diagnostical methods based thereonFARON PHARMACEUTICALS OY·Filed 2014·Granted Jan 7, 2020·0 cites·6 claims
- 1353US5851993ASuppression of tumor cell growth by syndecan-1 ectodomainBIOTIE THERAPIES LTD·Filed 1995·Granted Dec 22, 1998·21 cites·24 claims
- 1451US2010261253A1Glucuronyl C5-Epimerase, DNA encoding the same and uses thereofBIOTIE THERAPIES CORP·Filed 2008·Application pending·0 cites
- 1549US2010209942A1New biomarker for monitoring development of diseases and assessing the efficacy of therapiesFARON PHARMACEUTICALS OY A FIN·Filed 2008·Application pending·0 cites
- 1648US2004106654A1Inhibitors of copper-containing amine oxidasesFiled 2003·Application pending·0 cites
- 1746US11046761B2Humanized anti clever-1 antibodies and their useFARON PHARMACEUTICALS OY·Filed 2017·Granted Jun 29, 2021·0 cites·14 claims
- 1843US8722045B2Cell and therapeutical and diagnostical methods based thereonJALKANEN SIRPA·Filed 2010·Granted May 13, 2014·0 cites·2 claims
- 1942US2007093433A1Aminoglycoside antibiotics for use as vap-1/ssao inhibitorsJALKANEN SIRPA·Filed 2004·Application pending·0 cites
- 2041US2012115815A1Compositions useful especially for treatment or prevention of metabolic syndromeJALKANEN SIRPA·Filed 2012·Application pending·0 cites
- 2139US2011038922A1Compounds for treating or preventing amine oxidase related diseases or disordersFARON PHARMACEUTICALS OY a Finnish company·Filed 2006·Application pending·0 cites
- 2238US6017727ASyndecan enhancer element and syndecan stimulation of cellular differentiationBIOTIE THERAPIES LTD·Filed 1996·Granted Jan 25, 2000·4 cites·46 claims
- 2336US10884000B2Method of monitoring the efficacy of the anti-clever-1 therapy in cancerFARON PHARMACEUTICALS OY·Filed 2017·Granted Jan 5, 2021·0 cites·4 claims
- 2434US5422243ADetection of syndecan content in biological materials such as tissues and body fluids for indications of malignant transformations of cellsFiled 1993·Granted Jun 6, 1995·12 cites·16 claims
- 2532US6492344B1Syndecan enhancer element and syndecan stimulation of cellular differentiationBIOTIE THERAPIES CORP·Filed 1999·Granted Dec 10, 2002·1 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →